MENU
+Compare
SIBN
Stock ticker: NASDAQ
AS OF
Dec 18, 12:31 PM (EDT)
Price
$13.87
Change
+$0.03 (+0.22%)
Capitalization
672.23M

SIBN SI-BONE Forecast, Technical & Fundamental Analysis

a sacroiliac joint medical device company

SIBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for SIBN with price predictions
Dec 17, 2024

SIBN in upward trend: 10-day moving average broke above 50-day moving average on December 10, 2024

The 10-day moving average for SIBN crossed bullishly above the 50-day moving average on December 10, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 16, 2024. You may want to consider a long position or call options on SIBN as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SIBN just turned positive on November 29, 2024. Looking at past instances where SIBN's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

SIBN moved above its 50-day moving average on December 06, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SIBN advanced for three days, in of 291 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 58 cases where SIBN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SIBN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.828) is normal, around the industry mean (23.300). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (4.369) is also within normal values, averaging (43.338).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SIBN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SIBN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
SIBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SIBN is expected to report earnings to fall 7.50% to -14 cents per share on March 03

SI-BONE SIBN Stock Earnings Reports
Q4'24
Est.
$-0.15
Q3'24
Beat
by $0.08
Q2'24
Beat
by $0.06
Q1'24
Beat
by $0.04
Q4'23
Beat
by $0.01
The last earnings report on November 12 showed earnings per share of -15 cents, beating the estimate of -23 cents. With 51.15K shares outstanding, the current market capitalization sits at 672.23M.
A.I. Advisor
published General Information

General Information

a sacroiliac joint medical device company

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
471 El Camino Real
Phone
+1 408 207-0700
Employees
344
Web
https://www.si-bone.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EADIX17.26N/A
N/A
Eaton Vance Global Equity Income A
SCECX14.35N/A
N/A
Steward Values Enhanced SmMidCapI
FEIKX77.78-0.42
-0.54%
Fidelity Equity-Income K
JESSX15.65-0.13
-0.82%
Janus Henderson Global Sust Eq S
RPMIX9.40-0.11
-1.16%
Royce Small-Cap Fund Instl

SIBN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SIBN has been loosely correlated with QTRX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if SIBN jumps, then QTRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIBN
1D Price
Change %
SIBN100%
+0.51%
QTRX - SIBN
49%
Loosely correlated
-2.63%
KIDS - SIBN
41%
Loosely correlated
+0.81%
AORT - SIBN
41%
Loosely correlated
-0.21%
UTMD - SIBN
41%
Loosely correlated
-0.67%
NVRO - SIBN
38%
Loosely correlated
-2.41%
More